摘要 |
The present invention relates to a method of assessing whether a subject suffers from cancer or is prone to suffering from cancer, in particular lung cancer, comprising the measurement of the amounts of specific isoforms of GATA6 and/or NKX2-1 in a sample of said subject. Furthermore, the present invention relates to a composition for use in medicine comprising (an) inhibitor(s) of specific isoforms of GATA6 and/or NKX2-1. Additionally, the present invention relates to a kit for use in a method of assessing whether a subject suffers from cancer or is prone to suffering from cancer, in particular lung cancer. |
申请人 |
MAX-PLANCK GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.;JUSTUS-LIEBIG-UNIVERSITÄT GIESSEN |
发明人 |
BARRETO, GUILLERMO;MEHTA, ADITI;SINGH, INDRABAHADUR;SZIBOR, MARTEN;SAVAI, RAJKUMAR;SEEGER, WERNER;BRAUN, THOMAS;GÜNTHER, ANDREAS;KRÜGER, MARCUS |